Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will a U.S.-India Working Group do the Bidding of the Pharma Industry?
WSJ Pharmalot
Thursday, October 9, 2014 - 9:58am
tags:
India, generics
AstraZeneca ends Targacept partnership
Seeking Alpha
Thursday, October 9, 2014 - 9:57am
tags:
Targacept, AstraZeneca, AZD1446
Biotechs tap a swelling tide of investment cash to fund growing R&D ops
Fierce Biotech
Thursday, October 9, 2014 - 9:54am
tags:
biotech, R&D
Allergan Raises Profit Forecast as Valeant Pursues Bid
Bloomberg
Thursday, October 9, 2014 - 8:45am
tags:
Allergan, Valeant Pharmaceuticals, guidance
Endo to buy Auxilium for $2.6 billion, Auxilium drops QLT deal
Yahoo/Reuters
Thursday, October 9, 2014 - 8:40am
tags:
Endo Health Solutions, Auxilium, M&A, QLT
Glaxo to Take 25% Stake in Aspen Pharmacare Japanese Unit
Bloomberg
Thursday, October 9, 2014 - 8:35am
tags:
GSK, Aspen, Japan, M&A
Impax buys two private drugmakers for $700 mln
Yahoo/Reuters
Thursday, October 9, 2014 - 8:34am
tags:
Impax Laboratories, M&A, generics, Tower Holdings, Lineage Therapeutics
Levicept emerges from Pfizer's R&D ashes with $20M and a new pain drug
Forbes
Wednesday, October 8, 2014 - 8:46pm
tags:
Levicept, Pfizer, R&D, LEVI-04, painkillers
FDA Panel Gives Cautious Endorsement To Novel Boston Scientific Device
Forbes
Wednesday, October 8, 2014 - 8:35pm
tags:
FDA, advisory panels, devices, Boston Scientific, WATCHMAN, atrial fibrillation
Merck to release hep C data
Yahoo/Investors Business Daily
Wednesday, October 8, 2014 - 8:32pm
tags:
Merck, hepatitis C
Actavis deal for Allergan would be huge bet on branded drugs
Yahoo/Reuters
Wednesday, October 8, 2014 - 8:31pm
tags:
Actavis, Allergan, M&A
Ebola Drug Stocks React Wildly to Dallas Patient Death
24/7 Wall St
Wednesday, October 8, 2014 - 2:43pm
tags:
ebola virus, Tekmira, Biocryst, Chimerix, Sarepta Therapeutics
This CEO wants us to know as much about our bodies as we do about our credit cards
Fortune
Wednesday, October 8, 2014 - 2:39pm
tags:
Theranos, diagnostics
Dealpolitik: Allergan Battle May Showcase Unintended Consequences of Inversion Rules
WSJ Online
Wednesday, October 8, 2014 - 1:10pm
tags:
Allergan, Valeant Pharmaceuticals, M&A, tax inversions
Does Gilead Sciences Have a European Problem?
Barron's
Wednesday, October 8, 2014 - 1:07pm
tags:
Gilead Sciences, Europe, Sovaldi
FDA accepts sBLA for Lucentis label expansion
Seeking Alpha
Wednesday, October 8, 2014 - 1:06pm
tags:
FDA, Lucentis, Roche, Genentech, diabetic retinopathy
Cardiology groups endorse AZ's Brilinta over Plavix
Medical Marketing and Media
Wednesday, October 8, 2014 - 11:07am
tags:
AstraZeneca, cardiologists, Brilinta, Plavix
Salix’s Xifaxan Sales Expected To Go Downhill
Bidness Etc.
Wednesday, October 8, 2014 - 11:04am
tags:
Salix, Xifaxan, hepatitis C
Arrowhead Sinks on Disappointing Hepatitis B Drug Data
TheStreet.com
Wednesday, October 8, 2014 - 10:53am
tags:
Arrowhead Research, hepatitis B, ARC-520
Tekmira CEO says being a biotech is like being in ‘shark-infested water’
Marketwatch
Wednesday, October 8, 2014 - 10:51am
tags:
Tekmira Pharmaceuticals, Pharma CEOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.